Antiviral Research, volume 81, issue 1, pages 56-63

New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3

Schmidtke Michaela
Schmidtke Michaela 1
Wutzler Peter
Wutzler P. 1
Zieger Romy 1
Riabova Olga B 2
Makarov Vadim A
Publication typeJournal Article
Publication date2009-01-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.6
ISSN01663542, 18729096
Pharmacology
Virology
Abstract
Amino acid 1092 (AA1092) in capsid protein 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central phenoxy group of capsid binders (i.e. pleconaril). Whereas isoleucine is associated with drug susceptibility, leucine and methionine confer resistance to pleconaril. In the present study, novel analogues with different substitutions in the central phenoxy group were synthesized to study their influence on anti-CVB3 activity with the aim to overcome pleconaril resistance. Two [(biphenyloxy)propyl]isoxazoles and pleconaril were synthesized without methyl groups in the central phenoxy ring using Suzuki coupling reaction and tested for antiviral activity against the pleconaril-resistant CVB3 Nancy. Furthermore, pleconaril with 3-methyl, 3-methoxy, 3-bromine, 2,3-dimethyl in the central ring as well as the external rings in meta position were synthesized for structure-activity relationship analysis with CVB3 variants containing leucine, methionine or isoleucine at position 1092, other coxsackieviruses B (CVB) as well as several rhinoviruses. The results demonstrate a high impact of substituents in the central ring of capsid inhibitors for anti-enteroviral activity. Pleconaril resistance of CVB3 based on Leu1092 or Met1092 was overcome by unsubstituted analogues or by monosubstitution with 3-methyl as well as 3-bromine in the central phenyl. The 3-bromine derivative inhibited a broad spectrum of CVB and rhinoviruses.

Citations by journals

1
2
3
4
Antiviral Research
Antiviral Research, 4, 9.52%
Antiviral Research
4 publications, 9.52%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2, 4.76%
European Journal of Medicinal Chemistry
2 publications, 4.76%
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 2, 4.76%
Bioorganic and Medicinal Chemistry Letters
2 publications, 4.76%
Russian Journal of Infection and Immunity, 2, 4.76%
Russian Journal of Infection and Immunity
2 publications, 4.76%
Life
Life, 1, 2.38%
Life
1 publication, 2.38%
Current Organic Synthesis
Current Organic Synthesis, 1, 2.38%
Current Organic Synthesis
1 publication, 2.38%
Journal of Pediatric Hematology/Oncology
Journal of Pediatric Hematology/Oncology, 1, 2.38%
Journal of Pediatric Hematology/Oncology
1 publication, 2.38%
Future Medicinal Chemistry
Future Medicinal Chemistry, 1, 2.38%
Future Medicinal Chemistry
1 publication, 2.38%
Molecules
Molecules, 1, 2.38%
Molecules
1 publication, 2.38%
Microorganisms
Microorganisms, 1, 2.38%
Microorganisms
1 publication, 2.38%
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience, 1, 2.38%
Frontiers in Molecular Neuroscience
1 publication, 2.38%
Archives of Virology
Archives of Virology, 1, 2.38%
Archives of Virology
1 publication, 2.38%
Russian Chemical Bulletin
Russian Chemical Bulletin, 1, 2.38%
Russian Chemical Bulletin
1 publication, 2.38%
Monatshefte fur Chemie
Monatshefte fur Chemie, 1, 2.38%
Monatshefte fur Chemie
1 publication, 2.38%
Virology
Virology, 1, 2.38%
Virology
1 publication, 2.38%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 2.38%
Bioorganic and Medicinal Chemistry
1 publication, 2.38%
Journal of Molecular Structure
Journal of Molecular Structure, 1, 2.38%
Journal of Molecular Structure
1 publication, 2.38%
Ultrasonics Sonochemistry
Ultrasonics Sonochemistry, 1, 2.38%
Ultrasonics Sonochemistry
1 publication, 2.38%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 1, 2.38%
International Journal of Antimicrobial Agents
1 publication, 2.38%
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 1, 2.38%
Acta Pharmaceutica Sinica B
1 publication, 2.38%
ChemMedChem
ChemMedChem, 1, 2.38%
ChemMedChem
1 publication, 2.38%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.38%
Medicinal Research Reviews
1 publication, 2.38%
Nanoscale
Nanoscale, 1, 2.38%
Nanoscale
1 publication, 2.38%
Expert Review of Anti-Infective Therapy
Expert Review of Anti-Infective Therapy, 1, 2.38%
Expert Review of Anti-Infective Therapy
1 publication, 2.38%
Pathogens and Global Health
Pathogens and Global Health, 1, 2.38%
Pathogens and Global Health
1 publication, 2.38%
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 1, 2.38%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 2.38%
Research Results in Pharmacology
Research Results in Pharmacology, 1, 2.38%
Research Results in Pharmacology
1 publication, 2.38%
Pathogens and Disease
Pathogens and Disease, 1, 2.38%
Pathogens and Disease
1 publication, 2.38%
Journal of Virology
Journal of Virology, 1, 2.38%
Journal of Virology
1 publication, 2.38%
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 1, 2.38%
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 2.38%
1
2
3
4

Citations by publishers

2
4
6
8
10
12
14
Elsevier
Elsevier, 14, 33.33%
Elsevier
14 publications, 33.33%
Taylor & Francis
Taylor & Francis, 5, 11.9%
Taylor & Francis
5 publications, 11.9%
Springer Nature
Springer Nature, 4, 9.52%
Springer Nature
4 publications, 9.52%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 7.14%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 7.14%
Wiley
Wiley, 3, 7.14%
Wiley
3 publications, 7.14%
Saint Petersburg Pasteur Institute, 2, 4.76%
Saint Petersburg Pasteur Institute
2 publications, 4.76%
Bentham Science
Bentham Science, 1, 2.38%
Bentham Science
1 publication, 2.38%
Wolters Kluwer Health
Wolters Kluwer Health, 1, 2.38%
Wolters Kluwer Health
1 publication, 2.38%
Future Medicine
Future Medicine, 1, 2.38%
Future Medicine
1 publication, 2.38%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.38%
Frontiers Media S.A.
1 publication, 2.38%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 2.38%
Royal Society of Chemistry (RSC)
1 publication, 2.38%
Belgorod National Research University
Belgorod National Research University, 1, 2.38%
Belgorod National Research University
1 publication, 2.38%
Oxford University Press
Oxford University Press, 1, 2.38%
Oxford University Press
1 publication, 2.38%
American Society for Microbiology
American Society for Microbiology, 1, 2.38%
American Society for Microbiology
1 publication, 2.38%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 1, 2.38%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 2.38%
Universita Palackeho Olomouc, 1, 2.38%
Universita Palackeho Olomouc
1 publication, 2.38%
Electrochemical Science Group, University of Belgrade, 1, 2.38%
Electrochemical Science Group, University of Belgrade
1 publication, 2.38%
2
4
6
8
10
12
14
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Schmidtke M. et al. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3 // Antiviral Research. 2009. Vol. 81. No. 1. pp. 56-63.
GOST all authors (up to 50) Copy
Schmidtke M., Schmidtke M., Wutzler P., Wutzler P., Zieger R., Riabova O. B., Makarov V. A., Makarov V. A. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3 // Antiviral Research. 2009. Vol. 81. No. 1. pp. 56-63.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.antiviral.2008.09.002
UR - https://doi.org/10.1016%2Fj.antiviral.2008.09.002
TI - New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3
T2 - Antiviral Research
AU - Schmidtke, Michaela
AU - Wutzler, Peter
AU - Zieger, Romy
AU - Riabova, Olga B
AU - Makarov, Vadim A
AU - Schmidtke, Michaela
AU - Wutzler, P.
AU - Makarov, Vadim A.
PY - 2009
DA - 2009/01/01 00:00:00
PB - Elsevier
SP - 56-63
IS - 1
VL - 81
SN - 0166-3542
SN - 1872-9096
ER -
BibTex |
Cite this
BibTex Copy
@article{2009_Schmidtke,
author = {Michaela Schmidtke and Peter Wutzler and Romy Zieger and Olga B Riabova and Vadim A Makarov and Michaela Schmidtke and P. Wutzler and Vadim A. Makarov},
title = {New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3},
journal = {Antiviral Research},
year = {2009},
volume = {81},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016%2Fj.antiviral.2008.09.002},
number = {1},
pages = {56--63},
doi = {10.1016/j.antiviral.2008.09.002}
}
MLA
Cite this
MLA Copy
Schmidtke, Michaela, et al. “New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.” Antiviral Research, vol. 81, no. 1, Jan. 2009, pp. 56-63. https://doi.org/10.1016%2Fj.antiviral.2008.09.002.
Found error?